A few months after Dr. Orion Mercaitis leased a polo pony from Olivia Stringer in Aiken, S.C., their relationship took off at ...

VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...

Pfizer is pulling further away from the gene ... the complexities of the U.S. healthcare system.” Nevertheless, the Australian company has recently decided to shutter its cell and gene therapy ...

Data integration vendor Fivetran has enhanced its partner program with higher incentives, deeper go-to-market collaboration ...

Heart of Australia and Pfizer are aiming to expand its General Practitioner Education Program to bring their services to five new communities. Rural Editor Emily Minney spoke with Pfizer Australia ...

There is a word we should never have to utter during the next pandemic: “unprecedented”. That description was used so often, ...

Global data movement solutions provider Fivetran has announced the launch of an enhanced Partner Program, “making it easier ...

German COVID-19 vaccine maker BioNTech on Monday said that its 2025 revenues would likely fall to between 1.7 billion euros ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

It is already approved in Australia and Europe. Pfizer’s Australian unit made an offer to buy ResApp in April that valued the company at around A$100 million ($75 million), seeking ownership of ...